Free Trial

Aware Super Pty Ltd as trustee of Aware Super Buys Shares of 313,567 DocuSign, Inc. (NASDAQ:DOCU)

DocuSign logo with Computer and Technology background

Aware Super Pty Ltd as trustee of Aware Super bought a new position in DocuSign, Inc. (NASDAQ:DOCU - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 313,567 shares of the company's stock, valued at approximately $28,202,000. Aware Super Pty Ltd as trustee of Aware Super owned about 0.16% of DocuSign as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Kestra Investment Management LLC bought a new position in shares of DocuSign during the fourth quarter valued at about $30,000. Modus Advisors LLC purchased a new position in DocuSign during the 4th quarter valued at about $36,000. First Horizon Advisors Inc. raised its position in DocuSign by 102.6% during the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company's stock valued at $36,000 after purchasing an additional 201 shares during the last quarter. Bessemer Group Inc. lifted its holdings in DocuSign by 490.0% in the 4th quarter. Bessemer Group Inc. now owns 472 shares of the company's stock worth $42,000 after buying an additional 392 shares during the period. Finally, Avion Wealth grew its position in shares of DocuSign by 309.2% in the 4th quarter. Avion Wealth now owns 487 shares of the company's stock worth $43,000 after buying an additional 368 shares during the last quarter. Institutional investors own 77.64% of the company's stock.

DocuSign Stock Down 1.3 %

Shares of NASDAQ DOCU traded down $0.97 during trading on Friday, reaching $75.42. The company had a trading volume of 1,308,166 shares, compared to its average volume of 2,737,666. DocuSign, Inc. has a 12-month low of $48.70 and a 12-month high of $107.86. The business's 50-day moving average is $81.35 and its 200 day moving average is $83.10. The stock has a market cap of $15.27 billion, a PE ratio of 15.55, a P/E/G ratio of 6.94 and a beta of 1.20.

DocuSign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings data on Thursday, March 13th. The company reported $0.86 EPS for the quarter, beating the consensus estimate of $0.84 by $0.02. The company had revenue of $776.25 million for the quarter, compared to the consensus estimate of $760.94 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. DocuSign's revenue for the quarter was up 9.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.76 EPS. On average, analysts anticipate that DocuSign, Inc. will post 1.17 earnings per share for the current year.

Insider Activity at DocuSign

In other DocuSign news, insider Robert Chatwani sold 15,706 shares of the company's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $83.19, for a total transaction of $1,306,582.14. Following the transaction, the insider now owns 76,842 shares in the company, valued at approximately $6,392,485.98. This represents a 16.97 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Blake Jeffrey Grayson sold 8,000 shares of DocuSign stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $86.90, for a total transaction of $695,200.00. Following the completion of the sale, the chief financial officer now owns 77,851 shares of the company's stock, valued at $6,765,251.90. This represents a 9.32 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 55,851 shares of company stock valued at $4,607,439. 1.66% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

DOCU has been the subject of a number of recent analyst reports. Jefferies Financial Group decreased their target price on DocuSign from $115.00 to $105.00 and set a "buy" rating for the company in a report on Monday, March 31st. Wells Fargo & Company upped their price objective on shares of DocuSign from $70.00 to $73.00 and gave the stock an "underweight" rating in a report on Friday, March 14th. Wedbush reaffirmed a "neutral" rating and set a $100.00 target price on shares of DocuSign in a research note on Friday, March 14th. UBS Group reduced their price target on shares of DocuSign from $90.00 to $85.00 and set a "neutral" rating on the stock in a research report on Thursday. Finally, HSBC upgraded shares of DocuSign from a "reduce" rating to a "hold" rating and set a $70.00 price objective for the company in a report on Friday, April 11th. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and four have issued a buy rating to the stock. According to MarketBeat, DocuSign currently has an average rating of "Hold" and a consensus target price of $93.08.

View Our Latest Stock Report on DOCU

DocuSign Profile

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Further Reading

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Should You Invest $1,000 in DocuSign Right Now?

Before you consider DocuSign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.

While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?
Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines